Doctor Marisa Nieto

Centre for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Valladolid (Spain)

Follow

Contributor content

Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Presentation

Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

ESC 365 is supported by

novartis

Explore sponsored resources